Certain hormone replacement therapy tablets linked to increased heart disease and blood clot risk

Certain hormone replacement therapy (HRT) tablets containing both estrogen and progestogen are associated with a higher risk of heart disease and rare but serious blood clots known as venous thromboembolism (VTE) in women around the age of menopause, finds a study from Sweden published in The BMJ today.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup